Cargando…
Thiol-based angiotensin-converting enzyme 2 inhibitors: P(1′) modifications for the exploration of the S(1′) subsite
Explorations of the S(1′) subsite of ACE2 via modifications of the P(1′) methylene biphenyl moiety of thiol-based metalloprotease inhibitors led to improvements in ACE2 selectivity versus ACE and NEP, while maintaining potent ACE2 inhibition.
Autores principales: | Deaton, David N., Graham, Kevin P., Gross, Jeffrey W., Miller, Aaron B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd. Published by Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127737/ https://www.ncbi.nlm.nih.gov/pubmed/18243695 http://dx.doi.org/10.1016/j.bmcl.2008.01.046 |
Ejemplares similares
-
Thiol-based angiotensin-converting enzyme 2 inhibitors: P(1) modifications for the exploration of the S(1) subsite
por: Deaton, David N., et al.
Publicado: (2008) -
Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010) -
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020) -
Angiotensin-converting-enzyme inhibitor–induced angioedema
por: Quickfall, Danica, et al.
Publicado: (2021) -
Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)